GEFITINIB

GEFITINIB was reported 8990 times

GEFITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MITOCHONDRIAL ASPARTATE AMINOTRANSFERASE INCREASED 9 0.6429
1 PRIDE SYNDROME 8 0.4211
2 EGFR GENE MUTATION 130 0.3476
3 HER2 GENE AMPLIFICATION 3 0.2000
4 ACQUIRED GENE MUTATION 259 0.1976
5 MALIGNANT TRANSFORMATION 70 0.1559
6 SARCOMATOID CARCINOMA 6 0.1034
7 BRAF V600E MUTATION POSITIVE 4 0.0656
8 NON-SMALL CELL LUNG CANCER RECURRENT 18 0.0636
9 METASTASES TO MENINGES 118 0.0518
10 DRUG RESISTANCE 1253 0.0487
11 DRUG RESISTANCE MUTATION 8 0.0449
12 LYMPHANGIOSIS CARCINOMATOSA 43 0.0413
13 LUNG ADENOCARCINOMA STAGE IV 14 0.0367
14 PNEUMOCYSTIS CARINII PNEUMONIA 7 0.0345
15 BRAF GENE MUTATION 3 0.0333
16 METASTASES TO PLEURA 34 0.0324
17 METASTASES TO CENTRAL NERVOUS SYSTEM 377 0.0292
18 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 18 0.0290
19 PARONYCHIA 126 0.0286
20 METASTASES TO ADRENALS 24 0.0260
21 EMPHYSEMATOUS CYSTITIS 5 0.0235
22 GENE MUTATION 45 0.0227
23 XERODERMA 6 0.0225
24 CRYPTOGENIC ORGANIZING PNEUMONIA 4 0.0208
25 SMALL CELL LUNG CANCER 31 0.0205
26 LUNG INJURY 6 0.0199
27 METASTASES TO HEART 6 0.0199
28 METASTASES TO THE MEDIASTINUM 8 0.0194
29 MALIGNANT NEOPLASM PROGRESSION 1824 0.0178
30 MALIGNANT PLEURAL EFFUSION 30 0.0178
31 SMALL CELL CARCINOMA 6 0.0174
32 HANGNAIL 3 0.0173
33 METASTASES TO CHEST WALL 6 0.0173
34 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE EXACERBATED 6 0.0173
35 CARCINOEMBRYONIC ANTIGEN INCREASED 32 0.0165
36 MARKEDLY REDUCED DIETARY INTAKE 8 0.0162
37 CUTANEOUS SYMPTOM 11 0.0161
38 HEPATOBILIARY DISEASE 10 0.0160
39 METASTASES TO NECK 4 0.0143
40 DERMATITIS ACNEIFORM 84 0.0138
41 HYDROTHORAX 11 0.0133
42 BLOOD BETA-D-GLUCAN INCREASED 4 0.0130
43 ECZEMA ASTEATOTIC 6 0.0127
44 METASTASES TO KIDNEY 7 0.0127
45 SKIN CHAPPED 5 0.0124
46 RECALL PHENOMENON 10 0.0120
47 DYSPNOEA EXACERBATED 6 0.0117
48 DRUG INTERACTION POTENTIATION 3 0.0116
49 METASTASIS 83 0.0116
50 NON-SMALL CELL LUNG CANCER METASTATIC 10 0.0114
51 GROWTH OF EYELASHES 9 0.0114
52 CORNEAL EROSION 6 0.0111
53 CARCINOMA 3 0.0111
54 METASTASES TO BONE 181 0.0110
55 KERATOCONJUNCTIVITIS SICCA 4 0.0109
56 HYPOTRICHOSIS 7 0.0109
57 RADIATION PNEUMONITIS 23 0.0107
58 PYOGENIC GRANULOMA 5 0.0107
59 ARTERIAL THROMBOSIS LIMB 4 0.0097
60 NON-SMALL CELL LUNG CANCER 45 0.0094
61 ORAL INTAKE REDUCED 22 0.0091
62 METASTASES TO PANCREAS 4 0.0090
63 HYPERPLASIA 8 0.0089
64 METASTASES TO LUNG 102 0.0088
65 RADIATION NECROSIS 5 0.0087
66 PO2 DECREASED 10 0.0087
67 INTERSTITIAL LUNG DISEASE 420 0.0087
68 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 7 0.0085
69 CYSTITIS HAEMORRHAGIC 34 0.0084
70 XEROSIS 10 0.0081
71 BRONCHOPLEURAL FISTULA 3 0.0080
72 LUNG ADENOCARCINOMA 24 0.0080
73 PYODERMA 4 0.0079
74 ANOREXIA 100 0.0078
75 EXCESSIVE GRANULATION TISSUE 6 0.0074
76 SKIN TOXICITY 42 0.0074
77 PARANEOPLASTIC SYNDROME 5 0.0074
78 METASTASES TO LYMPH NODES 49 0.0073
79 COLLAPSE OF LUNG 6 0.0072
80 METASTASES TO SPINE 24 0.0071
81 DIFFUSE ALVEOLAR DAMAGE 8 0.0070
82 METASTASES TO LIVER 118 0.0067
83 HEPATIC FUNCTION ABNORMAL 248 0.0066
84 SUPERIOR VENA CAVA SYNDROME 4 0.0066
85 REFLUX OESOPHAGITIS 5 0.0066
86 RADIATION INJURY 7 0.0066
87 NAIL INFECTION 9 0.0063
88 SPUTUM CULTURE POSITIVE 5 0.0062
89 RADIATION SKIN INJURY 7 0.0060
90 PNEUMATOSIS INTESTINALIS 17 0.0060
91 LEUKOENCEPHALOPATHY 22 0.0059
92 CHEST X-RAY ABNORMAL 18 0.0059
93 NEUROENDOCRINE CARCINOMA 4 0.0058
94 CRANIAL NERVE DISORDER 4 0.0057
95 BLOOD PH INCREASED 3 0.0054
96 PERFORMANCE STATUS DECREASED 25 0.0054
97 ADENOCARCINOMA 12 0.0053
98 LYMPHADENOPATHY MEDIASTINAL 10 0.0052
99 SQUAMOUS CELL CARCINOMA OF LUNG 4 0.0052
100 LUNG NEOPLASM 22 0.0051
101 MUCOUS MEMBRANE DISORDER 7 0.0051
102 INGROWING NAIL 12 0.0051
103 EROSIVE DUODENITIS 4 0.0050
104 ACUTE PROMYELOCYTIC LEUKAEMIA 5 0.0049
105 CSF PROTEIN INCREASED 4 0.0048
106 IGA NEPHROPATHY 8 0.0048
107 ARTERITIS 3 0.0047
108 NEUROPATHY 8 0.0047
109 GASTROINTESTINAL MUCOSAL DISORDER 3 0.0046
110 NAIL DISORDER 40 0.0046
111 HILAR LYMPHADENOPATHY 4 0.0045
112 PNEUMOCYSTIS JIROVECI PNEUMONIA 10 0.0045
113 LUNG DISORDER 218 0.0044
114 TUMOUR MARKER INCREASED 21 0.0044
115 ONYCHOCLASIS 30 0.0044
116 ACUTE PRERENAL FAILURE 5 0.0043
117 LOBAR PNEUMONIA 8 0.0043
118 PERIODONTAL DISEASE 6 0.0043
119 SEBORRHOEIC DERMATITIS 7 0.0042
120 MULTIPLE-DRUG RESISTANCE 13 0.0042
121 LUNG CANCER METASTATIC 12 0.0042
122 CALCULUS URETERIC 3 0.0041
123 PCO2 DECREASED 4 0.0041
124 GASTRIC MUCOSAL LESION 3 0.0041
125 CEREBRAL ARTERY EMBOLISM 5 0.0041
126 LUNG INFILTRATION 36 0.0041
127 HYPOPHYSITIS 8 0.0040
128 PLEURAL EFFUSION 242 0.0040
129 COMPUTERISED TOMOGRAM ABNORMAL 9 0.0040
130 METASTASES TO PERITONEUM 10 0.0040
131 DRUG TOLERANCE 20 0.0039
132 CYTOLYTIC HEPATITIS 13 0.0039
133 DISEASE PROGRESSION 462 0.0039
134 ARTERIAL RUPTURE 3 0.0039
135 ASEPTIC NECROSIS BONE 3 0.0038
136 LIVER DISORDER 166 0.0037
137 ACNE PUSTULAR 3 0.0037
138 CORNEAL DISORDER 8 0.0036
139 POTENTIATING DRUG INTERACTION 12 0.0036
140 LUNG CONSOLIDATION 10 0.0036
141 RASH PUSTULAR 26 0.0036
142 OCCULT BLOOD POSITIVE 7 0.0036
143 CULTURE URINE POSITIVE 5 0.0036
144 CATHETER RELATED COMPLICATION 4 0.0035
145 BLOOD AMYLASE INCREASED 6 0.0035
146 HEPATOTOXICITY 78 0.0035
147 GLOMERULONEPHRITIS MEMBRANOUS 4 0.0034
148 DERMATITIS EXFOLIATIVE 17 0.0034
149 VOCAL CORD PARALYSIS 6 0.0033
150 GASTROINTESTINAL TOXICITY 16 0.0033
151 ATELECTASIS 32 0.0033
152 ENTEROCOLITIS INFECTIOUS 3 0.0033
153 HAEMOPTYSIS 90 0.0032
154 BRONCHOPNEUMONIA 11 0.0032
155 PULMONARY ALVEOLAR HAEMORRHAGE 18 0.0032
156 HENOCH-SCHONLEIN PURPURA 7 0.0032
157 PNEUMONIA BACTERIAL 29 0.0032
158 CEREBELLAR ATAXIA 3 0.0031
159 PNEUMONITIS 85 0.0031
160 CYSTITIS INTERSTITIAL 5 0.0031
161 EPIDERMAL NECROSIS 3 0.0031
162 SPINAL CORD COMPRESSION 12 0.0031
163 PURULENCE 6 0.0031
164 BONE MARROW DEPRESSION 3 0.0031
165 DUODENAL PERFORATION 3 0.0031
166 HAIR GROWTH ABNORMAL 21 0.0030
167 HAEMANGIOMA OF LIVER 3 0.0030
168 CATHETER RELATED INFECTION 3 0.0030
169 THERAPY PARTIAL RESPONDER 46 0.0029
170 DEAFNESS BILATERAL 5 0.0029
171 DISSEMINATED INTRAVASCULAR COAGULATION 41 0.0029
172 ALVEOLITIS ALLERGIC 3 0.0029
173 SUBILEUS 6 0.0029
174 ONYCHOMADESIS 12 0.0029
175 ALVEOLITIS 4 0.0028
176 BONE LESION 10 0.0028
177 CEREBRAL ATROPHY 11 0.0028
178 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 4 0.0028
179 ACINETOBACTER INFECTION 3 0.0027
180 CANCER PAIN 7 0.0027
181 ACUTE ABDOMEN 4 0.0027
182 PNEUMOTHORAX 43 0.0027
183 IMPETIGO 4 0.0027
184 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 3 0.0027
185 CHRONIC GASTRITIS 6 0.0027
186 NEOPLASM RECURRENCE 9 0.0027
187 HEPATIC CYST 9 0.0026
188 INFECTIOUS PLEURAL EFFUSION 4 0.0026
189 PATHOLOGICAL FRACTURE 13 0.0026
190 ACUTE LUNG INJURY 3 0.0025
191 BONE MARROW TOXICITY 3 0.0025
192 LACUNAR INFARCTION 6 0.0025
193 NEOPLASM PROGRESSION 87 0.0025
194 CLOSTRIDIUM COLITIS 3 0.0025
195 TUMOUR HAEMORRHAGE 7 0.0025
196 RECURRENT CANCER 10 0.0024
197 DIVERTICULAR PERFORATION 5 0.0024
198 HAEMOTHORAX 7 0.0024
199 VENA CAVA THROMBOSIS 4 0.0024
200 BLOOD LACTATE DEHYDROGENASE INCREASED 38 0.0024
201 OESOPHAGITIS 26 0.0024
202 PURPURA 21 0.0024
203 EROSIVE OESOPHAGITIS 4 0.0024
204 SKIN DISORDER 78 0.0023
205 CEREBRAL ISCHAEMIA 12 0.0023
206 MUCOSAL INFLAMMATION 61 0.0023
207 METASTATIC NEOPLASM 10 0.0023
208 PULMONARY HAEMORRHAGE 18 0.0023
209 SPLENIC INFARCTION 4 0.0023
210 LUNG OPACITY 6 0.0023
211 GASTROINTESTINAL ULCER 5 0.0023
212 HYPOXIA 79 0.0022
213 EOSINOPHILIC PNEUMONIA 7 0.0022
214 ALANINE AMINOTRANSFERASE INCREASED 136 0.0022
215 LARGE INTESTINAL ULCER 6 0.0022
216 SUBDURAL HAEMORRHAGE 6 0.0022
217 ASPARTATE AMINOTRANSFERASE INCREASED 116 0.0022
218 PLEURITIC PAIN 6 0.0022
219 CACHEXIA 11 0.0021
220 PUSTULE 5 0.0021
221 ENTEROCOLITIS 12 0.0021
222 PERICARDIAL EFFUSION 48 0.0021
223 CEREBRAL INFARCTION 50 0.0020
224 GAMMA-GLUTAMYLTRANSFERASE INCREASED 45 0.0020
225 ORGANISING PNEUMONIA 10 0.0020
226 SUFFOCATION FEELING 5 0.0020
227 EMPYEMA 4 0.0020
228 PROTHROMBIN TIME PROLONGED 12 0.0020
229 PROTEINURIA 38 0.0020
230 INTESTINAL ISCHAEMIA 11 0.0020
231 EYELID IRRITATION 5 0.0020
232 KERATITIS 6 0.0020
233 GLOSSITIS 7 0.0020
234 ASPARTATE AMINOTRANSFERASE ABNORMAL 3 0.0020
235 INCREASED BRONCHIAL SECRETION 5 0.0020
236 AORTIC ARTERIOSCLEROSIS 5 0.0019
237 LUNG NEOPLASM MALIGNANT 79 0.0019
238 RESPIRATORY FAILURE 140 0.0019
239 HEPATITIS TOXIC 5 0.0019
240 MOUTH ULCERATION 40 0.0019
241 TRANSAMINASES INCREASED 42 0.0019
242 BRAIN NEOPLASM 17 0.0018
243 SPUTUM INCREASED 4 0.0018
244 EXPOSED BONE IN JAW 4 0.0018
245 DUODENAL ULCER 13 0.0018
246 SKIN WRINKLING 5 0.0018
247 ULCERATIVE KERATITIS 5 0.0018
248 DEMENTIA ALZHEIMER'S TYPE 3 0.0018
249 HEPATITIS 46 0.0018
250 ILEUS PARALYTIC 8 0.0018
251 CEREBELLAR INFARCTION 3 0.0018
252 DRUG TOXICITY 24 0.0018
253 PULMONARY MASS 26 0.0017
254 SKIN ULCER 45 0.0017
255 SQUAMOUS CELL CARCINOMA 16 0.0017
256 STOMATITIS 103 0.0017
257 PHARYNGOLARYNGEAL PAIN 9 0.0017
258 HAEMORRHAGE SUBCUTANEOUS 6 0.0017
259 HEPATITIS FULMINANT 5 0.0017
260 BLOOD CULTURE POSITIVE 5 0.0017
261 BLOOD ALKALINE PHOSPHATASE INCREASED 41 0.0016
262 LIVER FUNCTION TEST ABNORMAL 48 0.0016
263 ACUTE RESPIRATORY DISTRESS SYNDROME 29 0.0016
264 BLOOD ALBUMIN DECREASED 13 0.0016
265 PURULENT DISCHARGE 7 0.0016
266 BONE MARROW FAILURE 33 0.0016
267 FOLLICULITIS 17 0.0016
268 CARDIAC DYSFUNCTION 6 0.0016
269 URINE OUTPUT DECREASED 14 0.0016
270 OSTEITIS 4 0.0016
271 BLOOD CREATINE INCREASED 7 0.0016
272 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
273 HYPERCOAGULATION 3 0.0016
274 DERMATITIS 33 0.0016
275 SKIN ATROPHY 9 0.0016
276 HEPATIC MASS 3 0.0016
277 STUPOR 5 0.0016
278 PULMONARY TOXICITY 11 0.0016
279 BLOOD UREA INCREASED 26 0.0016
280 LUNG INFECTION 24 0.0015
281 HEPATIC NEOPLASM 5 0.0015
282 HYPERSENSITIVITY VASCULITIS 4 0.0015
283 HYPOMAGNESAEMIA 21 0.0015
284 BRAIN OEDEMA 19 0.0015
285 BLOOD DISORDER 12 0.0015
286 MENINGITIS 10 0.0015
287 BLEPHARITIS 6 0.0015
288 ABDOMINAL MASS 4 0.0015
289 RASH 643 0.0015
290 HYDROCEPHALUS 8 0.0015
291 DEMYELINATION 6 0.0015
292 NEPHROTIC SYNDROME 10 0.0015
293 PIGMENTATION DISORDER 9 0.0015
294 ACUTE RESPIRATORY FAILURE 28 0.0015
295 ATRIAL THROMBOSIS 3 0.0014
296 RASH VESICULAR 7 0.0014
297 DRY SKIN 193 0.0014
298 INTRACRANIAL PRESSURE INCREASED 8 0.0014
299 SKIN INFECTION 16 0.0014
300 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
301 HAEMATEMESIS 36 0.0014
302 ABSCESS LIMB 6 0.0014
303 DIARRHOEA 907 0.0014
304 PNEUMONIA ASPIRATION 35 0.0014
305 DUODENAL ULCER HAEMORRHAGE 4 0.0014
306 DEPRESSED LEVEL OF CONSCIOUSNESS 55 0.0014
307 ACNE 105 0.0014
308 STRESS CARDIOMYOPATHY 8 0.0014
309 HAEMATOTOXICITY 13 0.0014
310 ILEUS 17 0.0014
311 ONYCHOMYCOSIS 6 0.0014
312 VULVOVAGINAL DISCOMFORT 6 0.0014
313 PLEURISY 8 0.0013
314 ODYNOPHAGIA 8 0.0013
315 HYDRONEPHROSIS 10 0.0013
316 MYELOSUPPRESSION 48 0.0013
317 EMBOLISM VENOUS 4 0.0013
318 DEHYDRATION 174 0.0013
319 RECTAL CANCER 4 0.0013
320 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 3 0.0013
321 GASTRITIS EROSIVE 6 0.0013
322 CARDIOPULMONARY FAILURE 5 0.0013
323 EPIGASTRIC DISCOMFORT 5 0.0013
324 ESCHERICHIA BACTERAEMIA 3 0.0013
325 CARDIAC TAMPONADE 6 0.0013
326 HEPATITIS B REACTIVATION 4 0.0013
327 NECROSIS 7 0.0013
328 HYPERBILIRUBINAEMIA 13 0.0013
329 CREATININE RENAL CLEARANCE DECREASED 5 0.0012
330 SKIN EROSION 4 0.0012
331 PULMONARY EMBOLISM 117 0.0012
332 NEUROLOGICAL SYMPTOM 7 0.0012
333 CARDIOMEGALY 15 0.0012
334 CEREBRAL DISORDER 9 0.0012
335 DEAFNESS NEUROSENSORY 4 0.0012
336 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 28 0.0012
337 CARDIAC FAILURE ACUTE 8 0.0012
338 NEPHRITIS 4 0.0012
339 HAIR TEXTURE ABNORMAL 16 0.0012
340 LEFT VENTRICULAR DYSFUNCTION 8 0.0012
341 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 4 0.0012
342 HYPERPYREXIA 5 0.0012
343 FEMORAL NECK FRACTURE 6 0.0012
344 PULMONARY TUBERCULOSIS 5 0.0012
345 INCREASED UPPER AIRWAY SECRETION 6 0.0012
346 HYPOALBUMINAEMIA 9 0.0012
347 INTERNATIONAL NORMALISED RATIO INCREASED 33 0.0012
348 HEPATIC LESION 5 0.0012
349 MICTURITION DISORDER 4 0.0012
350 PULMONARY FIBROSIS 22 0.0011
351 THROMBOPHLEBITIS 4 0.0011
352 EMBOLIC STROKE 4 0.0011
353 FIBRIN D DIMER INCREASED 4 0.0011
354 AREFLEXIA 3 0.0011
355 RETINAL HAEMORRHAGE 8 0.0011
356 TONGUE DISORDER 8 0.0011
357 DECUBITUS ULCER 9 0.0011
358 MULTI-ORGAN FAILURE 19 0.0011
359 HICCUPS 9 0.0011
360 ASPIRATION 12 0.0011
361 ESCHERICHIA INFECTION 9 0.0011
362 RENAL FAILURE ACUTE 46 0.0011
363 HAEMATURIA 37 0.0011
364 LEUKOPENIA 54 0.0011
365 CONJUNCTIVITIS 20 0.0011
366 HERPES SIMPLEX 7 0.0011
367 DRUG ERUPTION 19 0.0011
368 REFUSAL OF TREATMENT BY PATIENT 7 0.0011
369 PROTEIN TOTAL DECREASED 4 0.0011
370 GASTRIC ULCER 20 0.0011
371 SKIN HYPERPIGMENTATION 9 0.0010
372 MELAENA 23 0.0010
373 FAECAL INCONTINENCE 5 0.0010
374 GINGIVAL DISORDER 4 0.0010
375 GASTROINTESTINAL NECROSIS 3 0.0010
376 PULMONARY OEDEMA 46 0.0010
377 NAIL DISCOLOURATION 4 0.0010
378 RESPIRATORY RATE INCREASED 9 0.0010
379 DECREASED APPETITE 235 0.0010
380 FURUNCLE 8 0.0010
381 LARGE INTESTINE PERFORATION 7 0.0010
382 CREPITATIONS 3 0.0010
383 RENAL CYST 8 0.0010
384 BRAIN HERNIATION 3 0.0010
385 CANDIDIASIS 4 0.0010
386 CARDIAC FAILURE 80 0.0010
387 PNEUMOCYSTIS JIROVECII PNEUMONIA 10 0.0010
388 EMPHYSEMA 10 0.0010
389 LYMPHOPENIA 14 0.0010
390 KLEBSIELLA INFECTION 5 0.0010
391 ASCITES 29 0.0010
392 INGUINAL HERNIA 6 0.0010
393 DYSCHEZIA 3 0.0010
394 AMMONIA INCREASED 5 0.0010
395 HYPOKALAEMIA 45 0.0010
396 ENDOCARDITIS 5 0.0010
397 HAIR DISORDER 8 0.0010
398 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
399 STOMACH DISCOMFORT 5 0.0010
400 AORTIC DISSECTION 4 0.0010
401 RASH GENERALISED 25 0.0010
402 SKIN NECROSIS 5 0.0010
403 EYE DISCHARGE 10 0.0010
404 HEMIPLEGIA 8 0.0010
405 BLOOD CREATININE DECREASED 3 0.0010
406 NEOPLASM 11 0.0010
407 MOUTH HAEMORRHAGE 7 0.0010
408 GINGIVAL BLEEDING 13 0.0010
409 HYPOCALCAEMIA 18 0.0010
410 FACE OEDEMA 16 0.0009
411 ELECTROLYTE IMBALANCE 11 0.0009
412 ELECTROCARDIOGRAM QT PROLONGED 34 0.0009
413 BLADDER PAIN 3 0.0009
414 STAPHYLOCOCCAL INFECTION 31 0.0009
415 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0009
416 SKIN REACTION 13 0.0009
417 CHAPPED LIPS 4 0.0009
418 THROMBOCYTOPENIA 103 0.0009
419 MONOPLEGIA 4 0.0009
420 HEPATOMEGALY 9 0.0009
421 DISEASE RECURRENCE 43 0.0009
422 BRONCHOPULMONARY ASPERGILLOSIS 7 0.0009
423 GASTRIC ULCER HAEMORRHAGE 5 0.0009
424 COAGULOPATHY 15 0.0009
425 CARDIOTOXICITY 8 0.0009
426 COLITIS ISCHAEMIC 6 0.0009
427 HYPONATRAEMIA 50 0.0009
428 CLOSTRIDIAL INFECTION 3 0.0009
429 B-CELL LYMPHOMA 3 0.0009
430 DEATH 758 0.0009
431 HEPATIC FIBROSIS 3 0.0009
432 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
433 VISUAL DISTURBANCE 5 0.0009
434 PERITONITIS 18 0.0009
435 ANAEMIA 165 0.0009
436 PETECHIAE 9 0.0009
437 MASS 12 0.0009
438 LIVER INJURY 21 0.0009
439 FLANK PAIN 8 0.0009
440 BONE EROSION 3 0.0008
441 BLOOD CREATININE INCREASED 55 0.0008
442 EOSINOPHIL COUNT INCREASED 7 0.0008
443 PNEUMONIA 271 0.0008
444 ORAL CANDIDIASIS 11 0.0008
445 HEPATIC FAILURE 25 0.0008
446 CUTANEOUS VASCULITIS 3 0.0008
447 SKIN FISSURES 16 0.0008
448 ORAL DISORDER 6 0.0008
449 ULCER 13 0.0008
450 FEBRILE NEUTROPENIA 54 0.0008
451 AMYLASE INCREASED 3 0.0008
452 GENERAL PHYSICAL HEALTH DETERIORATION 94 0.0008
453 PROTEIN URINE PRESENT 4 0.0008
454 HEPATIC ENZYME ABNORMAL 4 0.0008
455 FLUID INTAKE REDUCED 4 0.0008
456 RENAL IMPAIRMENT 67 0.0008
457 DRUG-INDUCED LIVER INJURY 25 0.0008
458 ERYSIPELAS 4 0.0008
459 LYMPHADENOPATHY 28 0.0008
460 BODY TEMPERATURE INCREASED 16 0.0008
461 HYPOPHAGIA 20 0.0008
462 PYREXIA 270 0.0008
463 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
464 BLOOD BILIRUBIN INCREASED 21 0.0008
465 HEPATOCELLULAR INJURY 11 0.0008
466 VASCULITIS 9 0.0008
467 FAILURE TO THRIVE 4 0.0008
468 RETINAL DETACHMENT 7 0.0008
469 NERVE COMPRESSION 7 0.0008
470 HAEMATOCRIT DECREASED 15 0.0008
471 SUDDEN DEATH 8 0.0008
472 DEEP VEIN THROMBOSIS 49 0.0008
473 AZOTAEMIA 3 0.0008
474 DYSPHAGIA 71 0.0007
475 JAUNDICE 20 0.0007
476 BLOOD SODIUM DECREASED 14 0.0007
477 GINGIVITIS 4 0.0007
478 FRACTURE 14 0.0007
479 BLOOD POTASSIUM INCREASED 12 0.0007
480 TACHYPNOEA 10 0.0007
481 PULMONARY THROMBOSIS 8 0.0007
482 INFARCTION 5 0.0007
483 HYPERCALCAEMIA 9 0.0007
484 SPINAL COMPRESSION FRACTURE 6 0.0007
485 TOXIC EPIDERMAL NECROLYSIS 11 0.0007
486 GASTROINTESTINAL PERFORATION 3 0.0007
487 HYPERTRANSAMINASAEMIA 5 0.0007
488 SKIN DISCOLOURATION 33 0.0007
489 DEMENTIA 20 0.0007
490 HAEMODIALYSIS 6 0.0007
491 MACULAR OEDEMA 4 0.0007
492 PANCREATITIS ACUTE 16 0.0007
493 BUNDLE BRANCH BLOCK LEFT 3 0.0007
494 ACUTE MYELOID LEUKAEMIA 11 0.0007
495 SINUS TACHYCARDIA 10 0.0007
496 CARDIAC FAILURE CHRONIC 3 0.0007
497 MYOCARDIAL ISCHAEMIA 8 0.0007
498 HEPATIC PAIN 3 0.0007
499 SCAB 8 0.0007
500 OEDEMA 38 0.0007
501 ANURIA 6 0.0007
502 BLOOD MAGNESIUM DECREASED 6 0.0007
503 HERPES VIRUS INFECTION 4 0.0007
504 VOMITING 326 0.0007
505 FEEDING DISORDER 14 0.0007
506 NODULE 9 0.0007
507 ABSCESS 11 0.0007
508 RALES 4 0.0007
509 RESPIRATORY DISTRESS 19 0.0007
510 COUGH 193 0.0007
511 PLATELET COUNT DECREASED 73 0.0007
512 SPINAL OSTEOARTHRITIS 6 0.0007
513 WHITE BLOOD CELL COUNT INCREASED 26 0.0007
514 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
515 MEDICAL DEVICE COMPLICATION 5 0.0007
516 NERVOUS SYSTEM DISORDER 21 0.0007
517 COMA 32 0.0007
518 BRAIN NEOPLASM MALIGNANT 3 0.0007
519 PRODUCTIVE COUGH 32 0.0007
520 OEDEMA PERIPHERAL 81 0.0007
521 DYSPNOEA EXERTIONAL 25 0.0007
522 DELIRIUM 23 0.0007
523 NEUTROPHIL COUNT DECREASED 27 0.0007
524 BLOOD PRESSURE DECREASED 44 0.0007
525 HYPERTHERMIA 5 0.0007
526 EPILEPSY 20 0.0007
527 SHOCK 15 0.0007
528 SMALL INTESTINAL OBSTRUCTION 8 0.0006
529 DRUG INTERACTION 103 0.0006
530 MENTAL STATUS CHANGES 18 0.0006
531 OSTEONECROSIS OF JAW 16 0.0006
532 CARDIO-RESPIRATORY ARREST 27 0.0006
533 EJECTION FRACTION DECREASED 10 0.0006
534 TORSADE DE POINTES 5 0.0006
535 DENTAL CARIES 7 0.0006
536 NASAL DISCOMFORT 5 0.0006
537 ATRIAL FLUTTER 5 0.0006
538 MALNUTRITION 7 0.0006
539 NEUTROPENIA 85 0.0006
540 DYSURIA 23 0.0006
541 FISTULA 7 0.0006
542 HUMERUS FRACTURE 3 0.0006
543 RHINITIS 5 0.0006
544 MUSCLE DISORDER 5 0.0006
545 RESPIRATORY ARREST 17 0.0006
546 ANGINA UNSTABLE 4 0.0006
547 PLATELET COUNT INCREASED 8 0.0006
548 EATING DISORDER 13 0.0006
549 GASTROINTESTINAL HAEMORRHAGE 51 0.0006
550 OSTEOMYELITIS 11 0.0006
551 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
552 MULTIPLE ORGAN DYSFUNCTION SYNDROME 17 0.0006
553 FAECES DISCOLOURED 13 0.0006
554 TERMINAL STATE 4 0.0006
555 CYSTITIS 19 0.0006
556 CORONARY ARTERY STENOSIS 3 0.0006
557 HEMIPARESIS 10 0.0006
558 SUBARACHNOID HAEMORRHAGE 6 0.0006
559 EPISTAXIS 44 0.0006
560 CIRCULATORY COLLAPSE 10 0.0006
561 HEPATIC ENZYME INCREASED 40 0.0006
562 DYSPNOEA 332 0.0006
563 ECCHYMOSIS 4 0.0006
564 PSEUDOMONAS INFECTION 5 0.0006
565 ENCEPHALITIS 4 0.0006
566 VENTRICULAR EXTRASYSTOLES 6 0.0006
567 C-REACTIVE PROTEIN INCREASED 21 0.0006
568 APLASTIC ANAEMIA 3 0.0006
569 RASH PRURITIC 31 0.0006
570 GASTRITIS 15 0.0006
571 OXYGEN SATURATION DECREASED 32 0.0006
572 SKIN EXFOLIATION 48 0.0006
573 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
574 FACIAL PAIN 5 0.0006
575 HAEMOLYTIC ANAEMIA 5 0.0006
576 INTESTINAL OBSTRUCTION 21 0.0006
577 CHEILITIS 3 0.0006
578 ASTHENIA 207 0.0005
579 GASTROENTERITIS 8 0.0005
580 WEIGHT DECREASED 153 0.0005
581 FAECALOMA 3 0.0005
582 SKIN LESION 15 0.0005
583 BLINDNESS TRANSIENT 4 0.0005
584 CONVULSION 31 0.0005
585 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
586 ALOPECIA 106 0.0005
587 COLON CANCER 8 0.0005
588 CELLULITIS 27 0.0005
589 HAEMOGLOBIN DECREASED 55 0.0005
590 RASH PAPULAR 12 0.0005
591 APPENDICITIS 5 0.0005
592 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
593 NEPHROPATHY TOXIC 6 0.0005
594 THERAPY NON-RESPONDER 24 0.0005
595 INFECTION 77 0.0005
596 CHROMATURIA 12 0.0005
597 CHOLECYSTITIS ACUTE 3 0.0005
598 ENCEPHALOPATHY 13 0.0005
599 SEPTIC SHOCK 23 0.0005
600 PULMONARY HYPERTENSION 11 0.0005
601 GENERALISED ERYTHEMA 3 0.0005
602 GRANULOCYTOPENIA 3 0.0005
603 MICTURITION URGENCY 6 0.0005
604 MYOCARDITIS 6 0.0005
605 RENAL FAILURE CHRONIC 4 0.0005
606 RENAL FAILURE 69 0.0005
607 BLOOD URIC ACID INCREASED 3 0.0005
608 HAEMOLYSIS 4 0.0005
609 ECZEMA 27 0.0005
610 SEPSIS 57 0.0005
611 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
612 BACTERAEMIA 6 0.0005
613 TRICUSPID VALVE INCOMPETENCE 4 0.0005
614 WHITE BLOOD CELL COUNT DECREASED 54 0.0005
615 SENSORY LOSS 4 0.0005
616 TOXIC SKIN ERUPTION 5 0.0005
617 BONE DISORDER 9 0.0005
618 RENAL DISORDER 23 0.0005
619 RED BLOOD CELL COUNT DECREASED 14 0.0005
620 DYSPEPSIA 48 0.0005
621 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
622 GENERALISED OEDEMA 6 0.0005
623 MYELODYSPLASTIC SYNDROME 7 0.0005
624 CHOLANGITIS 3 0.0005
625 VISUAL ACUITY REDUCED 16 0.0005
626 EMBOLISM 4 0.0005
627 SECOND PRIMARY MALIGNANCY 4 0.0005
628 DRY EYE 24 0.0005
629 NAUSEA 380 0.0005
630 EYE PRURITUS 16 0.0005
631 CEREBRAL HAEMORRHAGE 17 0.0005
632 ACUTE MYOCARDIAL INFARCTION 14 0.0005
633 BLOOD URINE PRESENT 9 0.0005
634 FACIAL PARALYSIS 4 0.0005
635 ENTERITIS 3 0.0005
636 CHOLESTASIS 9 0.0005
637 INFLAMMATION 24 0.0005
638 APHASIA 14 0.0005
639 SPEECH DISORDER 24 0.0005
640 IMPAIRED HEALING 15 0.0005
641 BEDRIDDEN 6 0.0005
642 PULMONARY CONGESTION 6 0.0005
643 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
644 PRURITUS 174 0.0005
645 APPETITE DISORDER 3 0.0005
646 VENTRICULAR FIBRILLATION 5 0.0004
647 STEVENS-JOHNSON SYNDROME 10 0.0004
648 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
649 ORAL PAIN 10 0.0004
650 BRONCHIECTASIS 3 0.0004
651 BLOOD CALCIUM DECREASED 5 0.0004
652 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
653 CORONARY ARTERY OCCLUSION 6 0.0004
654 PERIPHERAL COLDNESS 6 0.0004
655 IRON DEFICIENCY ANAEMIA 4 0.0004
656 CARDIOVASCULAR DISORDER 11 0.0004
657 PERSONALITY CHANGE 4 0.0004
658 COORDINATION ABNORMAL 6 0.0004
659 BACTERIAL INFECTION 8 0.0004
660 BONE PAIN 25 0.0004
661 ABDOMINAL PAIN 99 0.0004
662 VENTRICULAR TACHYCARDIA 7 0.0004
663 PHOTOSENSITIVITY REACTION 7 0.0004
664 FLATULENCE 24 0.0004
665 SPUTUM DISCOLOURED 4 0.0004
666 CHOLECYSTITIS 5 0.0004
667 SUBDURAL HAEMATOMA 6 0.0004
668 POLYNEUROPATHY 5 0.0004
669 CANDIDA INFECTION 7 0.0004
670 DRUG INTOLERANCE 40 0.0004
671 PANCYTOPENIA 23 0.0004
672 THROMBOTIC MICROANGIOPATHY 4 0.0004
673 URINARY TRACT INFECTION 70 0.0004
674 CYTOPENIA 5 0.0004
675 RHABDOMYOLYSIS 17 0.0004
676 CARDIOMYOPATHY 6 0.0004
677 RASH MACULO-PAPULAR 9 0.0004
678 DYSGEUSIA 30 0.0004
679 PHARYNGITIS 5 0.0004
680 BLADDER DISORDER 4 0.0004
681 ATRIAL FIBRILLATION 39 0.0004
682 HERPES ZOSTER 23 0.0004
683 AMNESIA 26 0.0004
684 BRAIN INJURY 4 0.0004
685 LACRIMATION INCREASED 12 0.0004
686 VAGINAL DISCHARGE 4 0.0004
687 HYPOTHERMIA 4 0.0004
688 HEPATOCELLULAR CARCINOMA 3 0.0004
689 TASTE DISORDER 8 0.0004
690 ACIDOSIS 3 0.0004
691 MOTOR DYSFUNCTION 4 0.0004
692 HAEMORRHAGE 41 0.0004
693 CONFUSIONAL STATE 63 0.0004
694 URINARY RETENTION 13 0.0004
695 ERYTHEMA 80 0.0004
696 MUSCULOSKELETAL CHEST PAIN 6 0.0004
697 CARDIAC ARREST 32 0.0004
698 FEMUR FRACTURE 12 0.0004
699 MUSCULAR WEAKNESS 44 0.0004
700 LEUKOCYTOSIS 7 0.0004
701 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
702 TENDERNESS 4 0.0004
703 DEAFNESS 10 0.0004
704 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
705 CYANOSIS 6 0.0004
706 IMMUNE SYSTEM DISORDER 5 0.0004
707 DISORIENTATION 15 0.0004
708 INCONTINENCE 4 0.0004
709 RASH ERYTHEMATOUS 18 0.0004
710 HYPOTHYROIDISM 12 0.0004
711 BODY HEIGHT DECREASED 4 0.0004
712 URINARY INCONTINENCE 11 0.0004
713 RESPIRATORY DISORDER 11 0.0004
714 CHEST PAIN 68 0.0004
715 BLOOD POTASSIUM DECREASED 11 0.0004
716 OSTEONECROSIS 12 0.0004
717 BLOOD GLUCOSE FLUCTUATION 4 0.0004
718 EYE DISORDER 12 0.0004
719 POST PROCEDURAL COMPLICATION 7 0.0004
720 ABASIA 9 0.0004
721 ERUCTATION 7 0.0004
722 CHEST DISCOMFORT 37 0.0004
723 AGEUSIA 9 0.0004
724 GASTROOESOPHAGEAL REFLUX DISEASE 29 0.0004
725 NERVE INJURY 4 0.0004
726 NEOPLASM MALIGNANT 24 0.0004
727 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
728 INTESTINAL PERFORATION 4 0.0004
729 HYPOGLYCAEMIA 17 0.0004
730 PARALYSIS 5 0.0003
731 RECTAL HAEMORRHAGE 15 0.0003
732 HYPOTENSION 70 0.0003
733 CONDITION AGGRAVATED 106 0.0003
734 MUSCULOSKELETAL DISCOMFORT 6 0.0003
735 THROMBOSIS 28 0.0003
736 LETHARGY 20 0.0003
737 DIPLOPIA 9 0.0003
738 DYSARTHRIA 13 0.0003
739 MADAROSIS 4 0.0003
740 EYELID OEDEMA 4 0.0003
741 NEUROTOXICITY 6 0.0003
742 BLISTER 19 0.0003
743 TREATMENT FAILURE 28 0.0003
744 CHOLELITHIASIS 11 0.0003
745 CONSTIPATION 73 0.0003
746 GASTROINTESTINAL INFECTION 3 0.0003
747 GASTROINTESTINAL CARCINOMA 3 0.0003
748 FUNGAL INFECTION 11 0.0003
749 HYPERGLYCAEMIA 12 0.0003
750 DEVICE RELATED INFECTION 5 0.0003
751 THYROID DISORDER 5 0.0003
752 WOUND 9 0.0003
753 ERYTHEMA MULTIFORME 3 0.0003
754 HAIR COLOUR CHANGES 4 0.0003
755 TOOTH EXTRACTION 4 0.0003
756 WHEEZING 19 0.0003
757 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
758 SECRETION DISCHARGE 4 0.0003
759 EYE PAIN 18 0.0003
760 COLITIS 12 0.0003
761 OCULAR HYPERAEMIA 15 0.0003
762 CHILLS 37 0.0003
763 HYPERKALAEMIA 11 0.0003
764 GASTROINTESTINAL DISORDER 28 0.0003
765 DISCOMFORT 19 0.0003
766 FATIGUE 242 0.0003
767 HYPERTENSION 65 0.0003
768 BODY TEMPERATURE DECREASED 3 0.0003
769 COGNITIVE DISORDER 14 0.0003
770 PERICARDITIS 5 0.0003
771 PAIN OF SKIN 8 0.0003
772 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
773 DRY MOUTH 24 0.0003
774 EYELID PTOSIS 3 0.0003
775 DRUG LEVEL DECREASED 3 0.0003
776 LIMB INJURY 8 0.0003
777 TACHYCARDIA 26 0.0003
778 SCAR 5 0.0003
779 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
780 FALL 96 0.0003
781 BACK PAIN 67 0.0003
782 POLLAKIURIA 12 0.0003
783 FEELING COLD 8 0.0003
784 ORTHOSTATIC HYPOTENSION 5 0.0003
785 LOCAL SWELLING 5 0.0003
786 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
787 METABOLIC ACIDOSIS 9 0.0003
788 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 20 0.0003
789 ISCHAEMIC STROKE 5 0.0003
790 ABDOMINAL PAIN UPPER 57 0.0003
791 GASTRIC CANCER 7 0.0003
792 SKIN HAEMORRHAGE 4 0.0003
793 AGRANULOCYTOSIS 5 0.0003
794 HEPATIC STEATOSIS 5 0.0003
795 IMMUNODEFICIENCY 4 0.0003
796 ABDOMINAL DISCOMFORT 45 0.0003
797 LOWER RESPIRATORY TRACT INFECTION 12 0.0003
798 CARDIAC FAILURE CONGESTIVE 21 0.0003
799 GASTRIC HAEMORRHAGE 3 0.0003
800 HYPOAESTHESIA 39 0.0003
801 GLAUCOMA 5 0.0003
802 CHOKING 5 0.0003
803 ATAXIA 3 0.0003
804 NEUROPATHY PERIPHERAL 24 0.0003
805 NECK PAIN 14 0.0003
806 NIGHT SWEATS 8 0.0002
807 LOCALISED INFECTION 6 0.0002
808 VISION BLURRED 34 0.0002
809 ADRENAL INSUFFICIENCY 3 0.0002
810 PANCREATITIS 13 0.0002
811 BRADYCARDIA 13 0.0002
812 ANGINA PECTORIS 7 0.0002
813 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
814 MANIA 4 0.0002
815 HEART RATE INCREASED 24 0.0002
816 CEREBROVASCULAR ACCIDENT 41 0.0002
817 CYST 3 0.0002
818 DRUG LEVEL INCREASED 4 0.0002
819 DYSPHONIA 14 0.0002
820 NASOPHARYNGITIS 44 0.0002
821 OFF LABEL USE 209 0.0002
822 DERMATITIS ALLERGIC 3 0.0002
823 MALAISE 103 0.0002
824 DIZZINESS 117 0.0002
825 RETCHING 5 0.0002
826 SOMNOLENCE 47 0.0002
827 IRRITABLE BOWEL SYNDROME 5 0.0002
828 ANAPHYLACTIC SHOCK 6 0.0002
829 ARRHYTHMIA 11 0.0002
830 MENTAL DISORDER 10 0.0002
831 PRODUCT DOSE OMISSION 15 0.0002
832 DRUG INEFFECTIVE 299 0.0002
833 PAIN IN EXTREMITY 66 0.0002
834 MYOCARDIAL INFARCTION 39 0.0002
835 GLOSSODYNIA 5 0.0002
836 THROAT IRRITATION 10 0.0002
837 FREQUENT BOWEL MOVEMENTS 6 0.0002
838 TOOTHACHE 4 0.0002
839 BLINDNESS 9 0.0002
840 PALLOR 6 0.0002
841 ACUTE HEPATIC FAILURE 3 0.0002
842 TREATMENT NONCOMPLIANCE 12 0.0002
843 CATARACT 13 0.0002
844 MOVEMENT DISORDER 7 0.0002
845 MUSCLE SPASMS 40 0.0002
846 HIP FRACTURE 7 0.0002
847 THERAPY CESSATION 11 0.0002
848 FEELING HOT 13 0.0002
849 PAIN IN JAW 6 0.0002
850 DIALYSIS 3 0.0002
851 ABDOMINAL DISTENSION 22 0.0002
852 VIRAL INFECTION 7 0.0002
853 HYPERSOMNIA 6 0.0002
854 BLOOD PRESSURE FLUCTUATION 5 0.0002
855 LOWER LIMB FRACTURE 4 0.0002
856 HEPATIC CANCER 5 0.0002
857 PRODUCT USE ISSUE 39 0.0002
858 HYPERTHYROIDISM 3 0.0002
859 PRESCRIBED OVERDOSE 4 0.0002
860 FLUID OVERLOAD 3 0.0002
861 APATHY 3 0.0002
862 HAEMORRHOIDS 4 0.0002
863 LOSS OF CONSCIOUSNESS 26 0.0002
864 HAEMORRHAGE INTRACRANIAL 3 0.0002
865 SWELLING FACE 13 0.0002
866 HYPOAESTHESIA ORAL 3 0.0002
867 GAIT DISTURBANCE 38 0.0002
868 MEDICATION ERROR 11 0.0002
869 ABDOMINAL PAIN LOWER 5 0.0002
870 VERTIGO 12 0.0002
871 TOXICITY TO VARIOUS AGENTS 33 0.0002
872 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
873 CARDIAC DISORDER 18 0.0002
874 BASAL CELL CARCINOMA 3 0.0002
875 RESTLESSNESS 7 0.0002
876 MUSCULOSKELETAL PAIN 10 0.0002
877 SYNCOPE 19 0.0002
878 HALLUCINATION, VISUAL 4 0.0002
879 HEADACHE 118 0.0002
880 RHINORRHOEA 12 0.0002
881 PRURITUS GENERALISED 4 0.0002
882 MOOD ALTERED 5 0.0002
883 PAIN 112 0.0002
884 SEIZURE 21 0.0002
885 THERAPEUTIC RESPONSE DECREASED 11 0.0002
886 GAIT INABILITY 6 0.0002
887 ARTHRITIS 14 0.0002
888 ABNORMAL BEHAVIOUR 7 0.0002
889 BRONCHITIS 13 0.0002
890 EYE IRRITATION 10 0.0002
891 MUSCLE TWITCHING 4 0.0002
892 INSOMNIA 46 0.0002
893 HALLUCINATION 13 0.0002
894 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
895 EOSINOPHILIA 3 0.0002
896 PALPITATIONS 20 0.0002
897 HEAD DISCOMFORT 3 0.0002
898 GALLBLADDER DISORDER 3 0.0002
899 GOUT 3 0.0002
900 MOBILITY DECREASED 12 0.0002
901 DRUG EFFECT INCOMPLETE 6 0.0002
902 MENTAL IMPAIRMENT 4 0.0002
903 BLOOD PRESSURE INCREASED 25 0.0002
904 AGITATION 12 0.0002
905 HAEMATOCHEZIA 9 0.0002
906 BLOOD GLUCOSE ABNORMAL 3 0.0002
907 HYPERSENSITIVITY 30 0.0002
908 PRODUCT USE IN UNAPPROVED INDICATION 40 0.0002
909 SWELLING 15 0.0002
910 SWOLLEN TONGUE 5 0.0002
911 INTENTIONAL PRODUCT MISUSE 14 0.0002
912 MUSCULOSKELETAL STIFFNESS 14 0.0002
913 HEPATIC CIRRHOSIS 3 0.0002
914 UNRESPONSIVE TO STIMULI 4 0.0002
915 RESPIRATORY TRACT INFECTION 4 0.0002
916 SURGERY 9 0.0002
917 NEPHROLITHIASIS 7 0.0002
918 BLOOD PRESSURE ABNORMAL 3 0.0002
919 DYSKINESIA 6 0.0001
920 HYPERHIDROSIS 19 0.0001
921 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
922 RASH MACULAR 5 0.0001
923 BURNING SENSATION 10 0.0001
924 PARAESTHESIA 22 0.0001
925 FEELING ABNORMAL 33 0.0001
926 ACUTE KIDNEY INJURY 21 0.0001
927 VISUAL IMPAIRMENT 17 0.0001
928 INTENTIONAL PRODUCT USE ISSUE 12 0.0001
929 ACCIDENTAL OVERDOSE 5 0.0001
930 DEPRESSION 31 0.0001
931 LABORATORY TEST ABNORMAL 4 0.0001
932 MYALGIA 23 0.0001
933 EYE SWELLING 5 0.0001
934 HEART RATE IRREGULAR 3 0.0001
935 ILL-DEFINED DISORDER 8 0.0001
936 TINNITUS 6 0.0001
937 EXPOSURE DURING PREGNANCY 8 0.0001
938 PERIPHERAL SWELLING 19 0.0001
939 LIP SWELLING 4 0.0001
940 ADVERSE EVENT 11 0.0001
941 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
942 FLUID RETENTION 6 0.0001
943 MEMORY IMPAIRMENT 16 0.0001
944 HYPOACUSIS 5 0.0001
945 ASTHMA 13 0.0001
946 TREMOR 19 0.0001
947 CONTUSION 11 0.0001
948 HEART RATE DECREASED 4 0.0001
949 COLITIS ULCERATIVE 5 0.0001
950 WEIGHT INCREASED 25 0.0001
951 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
952 ANXIETY 31 0.0001
953 DRUG DOSE OMISSION 18 0.0001
954 ANAPHYLACTIC REACTION 6 0.0001
955 DIVERTICULITIS 3 0.0001
956 URTICARIA 18 0.0001
957 DYSSTASIA 3 0.0001
958 PLASMA CELL MYELOMA 4 0.0001
959 NASAL CONGESTION 6 0.0001
960 BLOOD GLUCOSE INCREASED 19 0.0001
961 CORONARY ARTERY DISEASE 3 0.0001
962 OROPHARYNGEAL PAIN 9 0.0001
963 ARTHRALGIA 40 0.0001
964 DRUG EFFECT DECREASED 5 0.0001
965 BALANCE DISORDER 8 0.0001
966 VAGINAL HAEMORRHAGE 4 0.0001
967 DIABETES MELLITUS 7 0.0001
968 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
969 ADVERSE DRUG REACTION 8 0.0001
970 ANGER 3 0.0001
971 PROSTATE CANCER 7 0.0001
972 BREAST CANCER 8 0.0001
973 BLADDER CANCER 5 0.0001
974 BLOOD GLUCOSE DECREASED 4 0.0001
975 HOT FLUSH 6 0.0001
976 SINUSITIS 8 0.0001
977 NO ADVERSE EVENT 14 0.0001
978 DEPRESSED MOOD 4 0.0001
979 INFLUENZA LIKE ILLNESS 6 0.0001
980 ARTHROPATHY 4 0.0001
981 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
982 FLUSHING 7 0.0001
983 IRRITABILITY 4 0.0001
984 CHRONIC KIDNEY DISEASE 5 0.0001
985 INFLUENZA 7 0.0001
986 INFUSION RELATED REACTION 4 0.0001
987 HOSPITALISATION 9 0.0001
988 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
989 DISTURBANCE IN ATTENTION 3 0.0001
990 PSORIASIS 7 0.0001
991 JOINT SWELLING 6 0.0000
992 OVERDOSE 10 0.0000
993 COVID-19 8 0.0000
994 MIGRAINE 4 0.0000
995 INCORRECT DOSE ADMINISTERED 5 0.0000
996 PRODUCT DOSE OMISSION ISSUE 5 0.0000